$7200 | Single User
$9000 | Site License
$12000 | Enterprise License

Drug Discovery Outsourcing Global Market – Forecast To 2025
[Lowest Price Guaranteed: $7,200]

Published by IQ4I: 14 Sep 2017 | 148219 | In Stock

Introduction

Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking for new sources of discovery and innovation with limited resources, there is a growing preference to move towards externalization and willingness to embrace the concept of outsourcing. IQ4I estimates that x – x% of the pharma companies R&D spending goes into drug discovery

Almost all the major Pharmaceutical companies are considering outsourcing as a core strategy to fill their discovery pipelines. Outsourcing companies that have precise capabilities through greater flexibility are the preferred ones. Now – a –days, the big pharma relies more on CRO’s for drug discovery capabilities to stock up their pipelines.

The global pharmaceutical outsourcing market was estimated to be $xx billion in 2016 and out of which xx% is accounted for CRO’s. Among the $xx billion CRO market, xx% accounts for discovery-based service i.e $xx billion in 2016 and xx% accounts for Preclinical service and clinical services.

Biologics are expected to grow faster at a CAGR of XX% during the forecast period 2016-25 compared to the small molecules which is growing at a CAGR of XX%. The growth is attributed to the increase in biologics R&D spending and lesser approval time, on the other hand factors such as tedious discovery process and high cost associated are restraining the biologics growth.

Current discovery outsourcing penetration is estimated to be XX% of the global pharmaceutical and biotech industry but poised to reach XX% by 2025 with a CAGR of X%. The pharmaceutical companies should consider several factors before finalizing a CRO partner like therapeutic area expertise, business model, scientific pool, infrastructure, data security, IP policies and last but not least cost-efficiency. Along with CRO’s expertise on drug discovery, the most important aspect the pharma companies look for in a CRO is a verified track record of successfully working in the discovery program of relevant therapeutic area.

Table of Contents
for Drug Discovery Outsourcing Global Market – Forecast To 2025

  • 1 INTRODUCTION

    2 MARKET ANALYSIS

    2.1 RESEARCH METHODOLOGY

    2.2 FORECASTING MODEL

    2.3 MARKET DYNAMICS

    2.4 MARKET SIZING

    2.5 EMERGING TRENDS & STRATEGIES

    3 BUSINESS OVERVIEW

    3.1 BUSINESS MODELS

    3.2 BUSINESS EVOLUTION

    3.3 CERTIFICATIONS

    3.4 DD INDICATORS

    3.5 PHARMA R&D EXP & INTENSITY

    4 COMPETITOR ANALYSIS

    4.1 THERAPEUTIC AREA MATRIX

    4.2 GLOBAL FTE RATES

    4.3 REGIONAL REVENUES VS FTE

    4.4 KEYPLAYERS (REVENUE PER EMPLOYEE, CUSTOMERS, DEALS & TA PIE CHART, COLLABORATION OUTCOMES)

    5 LEADING PLAYERS

    5.1 OVERVIEW

    5.2 CAPABILITIES

    5.3 THERAPEUTIC AREA

    5.4 BUSINESS MODELS

    5.5 COLLABORATIONS

    5.6 ACQUISITIONS

    6 MARKETING STRATEGIES

    6.1 CONFERENCES

    6.1.1 CONFERENCES - 2015, 2016, 2017

    6.1.2 CONFERENCE ANALYSIS- 2015-16

    6.2 MATCH MAKING WEBSITES

    6.3 VIRTUAL PHARMACEUTICALS

    6.4 ONLINE RPFS

    6.5 NETWORKING WEBSITES

    6.6 CLUSTERS

    6.7 OTHER MARKETING STRATEGIES

    6.7.1 WEBSITE RANKINGS

Additional Details

Publisher

IQ4I

Publisher Information

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.



We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Reference

148219 | Drug Discovery Outsourcing Global Market Report - 14092017

Number of Pages

203

Report Format

PDF

IQ4I Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Orphan Drug Commercial Models: Sustaining the rare disease business
IntroductionChoosing the right commercial model for orphan drug successThe societal and commercial a...
01 May 2016 by FirstWord Pharma USD $695 More Info
Pay-for-Performance and Drug Pricing: Impact and Response of Pharma [2016]
IntroductionThe pay for performance agenda gathers pace as US payers rebel the cost of drugs.Pharma ...
01 Mar 2016 by FirstWord Pharma USD $695 More Info
Innovations in Drug Pricing and Reimbursement (2016)
IntroductionIs the drug pricing bubble about to burst?Drug costs are becoming unaffordable and draco...
01 Feb 2016 by FirstWord Pharma USD $2,195 More Info
Drug Delivery - Innovations, trends, and their impact on pharma
IntroductionWhy you need Drug Delivery - Innovations, trends, and their impact on pharmaRevolutionar...
01 Nov 2015 by FirstWord Pharma USD $2,195 More Info
Physician Views: Which companies excel in diabetes drug marketing and why?
Scope With both the insulin and non-insulin segments of the diabetes market expected to become more ...
01 May 2015 by FirstWord Pharma USD $695 More Info
Trends and Innovations in Drug Pricing
IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends ...
01 Jan 2015 by FirstWord Pharma USD $695 More Info
Orphan Drug Market Access: Payer Insights on the Present and Future
IntroductionOrphan Drug Market Access: Payer Insights on the Present and Future is a report that exa...
14 Oct 2014 by FirstWord Pharma USD $695 More Info
Physician Views: With drug developers on the brink of Phase III for NASH, how large is the actual market opportunity?
Scope While no drugs are approved for non-alcoholic steatohepatitis (NASH), at least eight agents ha...
04 Aug 2014 by FirstWord Pharma USD $695 More Info
Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
ScopeSales of Biogen Idec’s multiple sclerosis therapy Tecfidera may continue to exceed initial expe...
01 Nov 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
01 Jun 2013 by FirstWord Pharma USD $695 More Info

This report is published by IQ4I

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Download Free Report Summary PDF

Drug Discovery Outsourcing Global Market – Forecast To 2025 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...